Skip to main navigation Skip to search Skip to main content

Cloning and characterization of Plasmodium vivax serine hydroxymethyltransferase

  • National Science and Technology Development Agency (NSTDA)

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

Serine hydroxymethyltransferase (SHMT), which catalyzes the reversible reaction of serine and tetrahydrofolate to glycine and methylenetetrahydrofolate, is one of the three enzymes in dTMP synthesis pathway that is highly active during cell division and has been proposed as a potential chemotherapeutic target in infectious diseases and cancer. This is the first study to describe nucleotide and amino acid sequences of SHMT from the malaria parasite Plasmodium vivax. Sequencing of 12 P. vivax isolates revealed limited polymorphisms in 3 noncoding regions. Its biological function is also reported.

Original languageEnglish
Pages (from-to)223-228
Number of pages6
JournalParasitology International
Volume57
Issue number2
DOIs
Publication statusPublished - Jun 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Plasmodium vivax
  • Serine hydroxymethyltransferase
  • dTMP cycle

Fingerprint

Dive into the research topics of 'Cloning and characterization of Plasmodium vivax serine hydroxymethyltransferase'. Together they form a unique fingerprint.

Cite this